FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents aqueous composition for stabilisation of follicle-stimulating hormone, which includes follicle-stimulating hormone and combination of histidine and methionine as stabilising means, where histidine concentration constitutes from 0.05 to 10.0 mg/ml and concentration of methionine constitutes from 0.05 to 10 mg/ml, sucrose and phosphate buffer substance.
EFFECT: invention provides application of histidine and methionine combination as stabilising means for substance of protein nature, in particular follicle-stimulating hormone, in aqueous composition.
10 cl, 5 ex, 5 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS COMPOSITION OF RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (VERSIONS) | 2015 |
|
RU2599031C1 |
| WATER-BASED HFSH COMPOSITIONS | 2006 |
|
RU2407514C2 |
| GONADOTROPIN-CONTAINING LIQUID COMPOSITIONS | 1998 |
|
RU2203086C2 |
| FLUID FORMULATION OF FOLLICLE-STIMULATING HORMONE | 2011 |
|
RU2553375C2 |
| CELL LINE HUFSHKKC6, PRODUCER OF RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE (FSH) AND METHOD FOR PRODUCING FSH USING SAID LINE | 2018 |
|
RU2694598C1 |
| PURIFIED FOLLICLE-STIMULATING HORMONE (FSH), PHARMACEUTICAL COMPOSITION, A COMPONENT OF PHARMACEUTICAL COMPOSITION | 1988 |
|
RU2105012C1 |
| LIGANDS TO RECEPTOR OF FOLLICLE-STIMULATING HORMONE (FSH) IN DIAGNOSTICS AND TREATMENT OF TUMORS | 2017 |
|
RU2755000C2 |
| FSH STABILISATION | 2011 |
|
RU2574012C2 |
| COMPOSITION OF FACTOR VIII | 2015 |
|
RU2689338C2 |
| STABLE AQUEOUS PROTEIN COMPOSITIONS OF MIA/CD-RAP | 2011 |
|
RU2739078C2 |
